Talis Biomedical Profit Margin

Talis Biomedical (TLIS) currently reports a profit margin of -17008.67% as of June 2024. That compares with -6837.56% in the prior-year period — down 148.8% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Talis Biomedical's profit margin history and peer comparisons.

Talis Biomedical's profit margin decreased from -6837.56% to -17008.67% — a 148.8% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Talis Biomedical's profit margin of -17008.67% is lower than the Healthcare sector average of 13.89%. That is roughly 122525.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Talis Biomedical's current -17008.67% should be judged against Healthcare norms (sector average: 13.89%) and against TLIS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -17008.67%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Talis Biomedical, and consider following TLIS for alerts when major investors trade the stock.